Clinical trial · Observational
Breast Cancer Chemotherapy Risk Prediction Mathematical Model
Macro-microscopic Syndrome Differentiation and Combination，Based on the "Chinese Medicine Clinical Phenotype" to Construct Breast Cancer Chemotherapy Risk Prediction Mathematical Model
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This is a cohort study. This study is to develop a predictive model of the side effects after chemotherapy, exploreing the potential risk factors of the side effects such as myelosuppression and chemotherapy realted vomit after the chemotherapy, so that it could help to alleviate patients' fear and anxiety about the side effects and the toxicity of chemotherapy. The potential risk factors were measured at baseline.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Neoplasms | Breast Neoplasm | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (1)
- label
- All
- description
- The side effects after chemotherapy were observed for all patients. Potential risk factors would be explored for the side effects such as chemotherapy realted vomit.
Primary outcomes (1)
- measure
- Myelosuppression of chemotherapy
- timeFrame
- 6 month
- description
- Outcome is a bianry outcome, Yes or No variable. The primary outcome is wether the bone marrow suppression occurred or not for patients during the chemotherapy.
Secondary outcomes (1)
- measure
- Chemotherapy related vomit (side effects of chemotherapy)
- timeFrame
- 6 month
- description
- Outcome is a bianry outcome, Yes or No variable. The secondary outcome is wether the chemotherapy realted vomit occurred or not for patients during the chemotherapy.
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: * THe female patients diagnosed with breast cancer by first histopathology; * No tumor intervention therapy was conducted within one prior to the survey; * KPS score≥60; * Patients without sever idiopathic disease; * Patients who can independently respond to a questionnaire * Those who signed informed consent Exclusion Criteria: * Patients with sever idiopathic disease of the gastrointestinal tract, heart and blood vessels, liver,kidney, hematopoietic system, endocrine system and so on; * Patients with previous or nogoing application of drugs affecting bone marrow hemoatopoietic function; * Patients who complicated with a serious infection or severe liquid sickness; * Psychiatric patients; * Those who can not independently respond to a questionnaire
References
Publications (0)
Data not yet available